IQIRVO 80 mg/1

IQIRVO 80 mg is a film-coated tablet containing elafibranor, used for managing metabolic disorders. This oral medication is designed to support liver health and metabolic function.

IQIRVO 80 mg is primarily used for the management of metabolic disorders, including non-alcoholic steatohepatitis (NASH). This medication works by targeting specific receptors involved in metabolic processes, helping to improve liver function and overall metabolic health. People often ask, 'What is IQIRVO used for?' and the answer lies in its role in supporting liver health and metabolic balance.

Common effects of IQIRVO 80 mg may include improvements in liver function markers and metabolic parameters. Some users may experience mild gastrointestinal discomfort or changes in appetite. These effects can vary from person to person, and it's important to monitor how the body responds to the medication.

IQIRVO 80 mg should be handled with care, following the prescribed guidelines. It is essential to consult a healthcare provider before starting this medication, especially if you have pre-existing conditions or are taking other medications. Always store the tablets in a cool, dry place away from direct sunlight.

IQIRVO 80 mg may interact with certain medications, including those metabolized by the liver's cytochrome P450 system. It is advisable to avoid alcohol while taking this medication, as it can affect liver function. Always inform your healthcare provider about all the medications you are taking to avoid potential interactions.